Drug profile · INN
lipotecan
lipotecan is a dna topoisomerase i inhibitor.
NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — lipotecan
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.70
Quick answer
lipotecan is a dna topoisomerase i inhibitor.
Key facts
INN lipotecan
Mechanism DNA topoisomerase I inhibitor
Target DNA topoisomerase 1
Mechanism of action
DNA topoisomerase I inhibitor
Primary target: DNA topoisomerase 1
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is lipotecan?
lipotecan is a dna topoisomerase i inhibitor.